Search for
Search for
News
GE2020
COVID-19
Lifestyle
Lifestyle news
Good deals
Trend
Drama
Things to eat
Things to do
Stories of us
Celebrity
Dildo
Travel
Videos
Foreign
Weekend
Ambient
+ More
Technology
Viewpoints
Parliament
The history
AHTC test
Careers
Search for
News
GE2020
COVID-19
Lifestyle
Lifestyle news
Good deals
Trend
Drama
Things to eat
Things to do
Stories of us
Celebrity
Dildo
Travel
Videos
Foreign
Weekend
Ambient
+ More
Technology
Viewpoints
Parliament
The history
AHTC test
Careers
Search for
← Back
A large-scale trial for a leading Covid-19 vaccine candidate was suspended after a gamer had an unexplained illness.
The trial concerned a vaccine developed through the pharmaceutical company AstraZeneca and the University of Oxford reported Stat News, a fitness data produced through the Boston Globe.
A September 8 company said that its “standard review procedure has been activated. “
Here’s the update from $ AZN, which makes it clear that the company * voluntarily * stopped vaccination in its P3 trial. https://t. co/kmjVIHGY1T pic. twitter. com/twitF5EFES
“We have voluntarily suspended vaccination to allow review of protection knowledge through an independent committee. “
The player collects
The disease has been reported in the UK, but the main points surrounding it have been revealed.
According to Stat News, the affected player is expected to recover.
“In giant lawsuits, diseases will occur by chance,” he said. “We are racing to expedite the review of the single occasion to minimize any possible effect on the timing of the trial. “
Stat News reported that clinical blocks are unusual in vaccine development and it is known how long AstraZeneca will last.
Nine vaccines in 3 trials
The company’s vaccine is one of nine vaccines recently in phase 3 trials, the phase prior to the approval of the vaccines.
The vaccine had been the subject of two/3 trials in England and India, and 3 trials in Brazil, South Africa and the United States, according to the New York Times.
This is the first trial of the III Covid-19 vaccine known to have been suspended.
Reuters reported that AstraZeneca shares fell more than 8% after the announcement of the shutdown.
By contrast, stocks from rival vaccine developers such as Moderna and Pfizer have risen.
The 3 pharmaceutical corporations were among the nine most sensible US and European vaccine developers who pledged on September 8 to “uphold the integrity of the clinical process. “
According to Reuters, the “historic compromise” came after emerging fears that criteria for protection and efficacy could slip as the world scrambled to find a solution to the Covid-19 pandemic.
SGH website top symbol